33125-97-2

What is etomidate?

Etomidate is a short-acting intravenous anesthetic frequently used for inducing general anesthesia. Its rapid onset and quick recovery make it especially suitable for patients with compromised cardiovascular health. The drug enhances the action of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, resulting in sedation and unconsciousness. Because etomidate has minimal impact on heart rate and blood pressure, it is considered a safe option for those needing fast sedation. However, due to possible side effects like adrenal suppression, etomidate is typically reserved for short procedures or used as part of a balanced anesthetic approach.

Etomidate mechanism of action

Etomidate exerts its anesthetic effects by modulating the activity of the GABA neurotransmitter system. Specifically, it enhances the binding of GABA to its receptors, particularly the GABA-A receptor, which increases the influx of chloride ions into neurons. This hyperpolarises the cell membrane, leading to decreased neuronal excitability and resulting in sedation and unconsciousness. Due to its high lipid solubility, etomidate rapidly crosses the blood-brain barrier, allowing for swift onset of action. Its short duration of action is mainly attributed to the rapid redistribution of the drug from the brain to other tissues, which allows for a quick recovery following administration.

What is etomidate used for?

Etomidate is primarily used as an intravenous anesthetic for the induction of general anesthesia, particularly in settings where rapid onset and quick recovery are essential. Its unique pharmacological profile makes it a suitable choice for patients with cardiovascular instability, as it has minimal effects on heart rate and blood pressure.

In addition to its use in general anesthesia, etomidate is often employed for procedural sedation in emergency medicine and critical care settings, enabling rapid sedation for various procedures such as intubation or diagnostic imaging. It is also beneficial in patients at risk of hemodynamic complications due to its cardiovascular stability.

Etomidate is sometimes used for sedation in intensive care units (ICUs) when patients require brief periods of unconsciousness without significant hemodynamic effects. However, its use is typically limited to short-term sedation due to its potential to cause adrenal suppression with prolonged administration.

Why choose Bachem as your etomidate API manufacturer?

When it comes to sourcing etomidate, Bachem stands out as a trusted API manufacturer known for quality and reliability. With decades of expertise in peptide and small molecule synthesis, we leverage advanced manufacturing capabilities to produce high-purity etomidate that meets stringent regulatory standards. Our facilities are GMP-certified, ensuring that every batch is produced with the utmost care and precision.

Bachem offers a flexible approach, capable of fulfilling orders ranging from grams to multi-kilograms, adapting to your specific needs while guaranteeing timely delivery. We pride ourselves on our customer-centric service, providing comprehensive regulatory support, including access to Drug Master Files (DMFs) and Certificates of Suitability (CEPs).

Our commitment to innovation drives us to continuously optimise our processes, resulting in efficient production methods that help reduce lead times and costs. Choose Bachem for your etomidate API needs and experience the benefits of a dedicated and experienced partner.

How do we tailor our services to meet your needs?

At Bachem, we understand that every client has unique requirements, and we’re dedicated to providing tailored solutions that truly fit your needs. Our flexible production capabilities allow us to handle orders of all sizes, whether you need a small batch or a large industrial quantity of etomidate. This adaptability ensures you receive exactly what you require, right when you need it.

We prioritise building strong relationships with our clients. Our knowledgeable team works closely with you throughout the entire process, offering personalised support, including customised regulatory documentation and guidance tailored to your specific situation.

By continuously refining our processes and adopting the latest technologies, we aim to enhance lead times and maintain exceptional quality. Our focus on clear communication and collaboration ensures our services align with your goals. With Bachem, you gain a reliable partner committed to understanding your challenges and helping you succeed in a competitive market.

Related generic APIs and services

Discover our selection of high-quality generic APIs, including Carbidopa, Icatibant Acetate, and Buserelin Acetate. Explore our custom synthesis and regulatory support services for seamless solutions

Anesthesia

The imidazole derivative etomidate is a rapid, short acting intravenous anesthetic agent. Etomidate, a GABA-A receptor agonist, acts as a sedative but not as an analgesic. A relative lack of significant hemodynamic and respiratory effects is a further reason for choosing etomidate for inducing anesthesia. Etomidate is applied as a sedative or anesthetic especially in emergency medicine. The anesthetic has also found use in small animal veterinary practice.

Molecular Formula

C₁₄H₁₆N₂O₂

Relative Molecular Mass

244.29 g/mol

Long-term Storage

Room temperature

Contact US